Literature DB >> 23876378

The relationships among hemostatic markers, the withdrawal of fondaparinux due to a reduction in hemoglobin and deep vein thrombosis in Japanese patients undergoing major orthopedic surgery.

Masahiro Hasegawa1, Hideo Wada, Hiroki Wakabayashi, Kakunoshin Yoshida, Noriki Miyamoto, Kunihiro Asanuma, Takeshi Matsumoto, Kohshi Ohishi, Yuji Shimokariya, Norikazu Yamada, Atsumasa Uchida, Akihiro Sudo.   

Abstract

BACKGROUND: The relationships among the hemostatic markers, the development of deep vein thrombosis (DVT) and the withdrawal of fondaparinux due to a reduction in the hemoglobin levels were examined.
METHODS: Two-hundred twenty-one Japanese patients who underwent major orthopedic surgery and were treated with 1.5mg of fondaparinux instead of 2.5mg of fondaparinux were studied. Forty-seven of 221 patients discontinued fondaparinux treatment (withdrawal group) and 37 patients developed DVT.
RESULTS: The age, frequency of total knee arthroplasty (TKA), withdrawal of fondaparinux, reduction of hemoglobin and the plasma levels of soluble fibrin (SF), D-dimer and fibrinogen and fibrin degradation product (FDP) on day 1 after the operation were significantly higher in the patients with DVT. Elevated SF, D-dimer or FDP levels were associated with the risk for DVT. The age, frequency of TKA or DVT, anti-Xa activity and the creatinine, FDP and D-dimer levels were significantly higher in the withdrawal group. An anti-Xa level >0.33 mg/l and an elevated D-dimer or FDP level were associated with the risk of withdrawal.
CONCLUSION: The age and SF levels, TKA and withdrawal of fondaparinux were related to the risk of DVT, and the anti-Xa activity, creatinine level and DVT were related to the risk of withdrawal of fondaparinux due to a reduction in hemoglobin.
© 2013.

Entities:  

Keywords:  Anti-Xa activity; Deep vein thrombosis (DVT); Fondaparinux; Orthopedic surgery; Withdrawal

Mesh:

Substances:

Year:  2013        PMID: 23876378     DOI: 10.1016/j.cca.2013.07.009

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  12 in total

1.  The Evaluation of D-Dimer Levels for the Comparison of Fibrinogen and Fibrin Units Using Different D-Dimer Kits to Diagnose VTE.

Authors:  Masahiro Hasegawa; Hideo Wada; Toshio Yamaguchi; Hiroki Wakabayashi; Naoki Fujimoto; Takeshi Matsumoto; Kei Hasegawa; Norikazu Yamada; Masaaki Ito; Yoshiki Yamashita; Naoyuki Katayama; Kaname Nakatani; Akihiro Sudo
Journal:  Clin Appl Thromb Hemost       Date:  2017-05-08       Impact factor: 2.389

2.  Elevated soluble platelet glycoprotein VI is a useful marker for DVT in postoperative patients treated with edoxaban.

Authors:  Takumi Aota; Katsuki Naitoh; Hideo Wada; Yoshiki Yamashita; Noriki Miyamoto; Masahiro Hasegawa; Hiroki Wakabayashi; Kakunoshin Yoshida; Kunihiro Asanuma; Takeshi Matsumoto; Kohshi Ohishi; Yuji Shimokariya; Norikazu Yamada; Masakatsu Nishikawa; Naoyuki Katayama; Atsumasa Uchida; Akihiro Sudo
Journal:  Int J Hematol       Date:  2014-09-25       Impact factor: 2.490

3.  Comparison of three different anti-Xa assays in major orthopedic surgery patients treated with fondaparinux.

Authors:  Makoto Ikejiri; Hideo Wada; Toshio Yamaguchi; Shinichi Miyazaki; Masahiro Hasegawa; Hiroki Wakabayashi; Kunihiro Asanuma; Akane Sakaguchi; Takeshi Matsumoto; Kohshi Ohishi; Naoki Fujimoto; Norikazu Yamada; Masaaki Ito; Naoyuki Katayama; Akihiro Sudo
Journal:  Int J Hematol       Date:  2016-02-27       Impact factor: 2.490

4.  Fibrin-related markers for diagnosing acute-, subclinical-, and pre-venous thromboembolism in patients with major orthopedic surgery.

Authors:  Toshio Yamaguchi; Hideo Wada; Shinichi Miyazaki; Masahiro Hasegawa; Hiroki Wakabayashi; Kunihiro Asanuma; Naoki Fujimoto; Takeshi Matsumoto; Kohshi Ohishi; Akane Sakaguchi; Norikazu Yamada; Masaaki Ito; Yoshiki Yamashita; Naoyuki Katayama; Akihiro Sudo
Journal:  Int J Hematol       Date:  2016-02-12       Impact factor: 2.490

5.  High frequency of decreased antithrombin level in pregnant women with thrombosis.

Authors:  Yuki Kamimoto; Hideo Wada; Makoto Ikejiri; Kaname Nakatani; Takashi Sugiyama; Kazuhiro Osato; Nao Murabayashi; Norikazu Yamada; Takeshi Matsumoto; Kohshi Ohishi; Hidehiro Ishikawa; Hidekazu Tomimoto; Masaaki Ito; Tomoaki Ikeda
Journal:  Int J Hematol       Date:  2015-07-02       Impact factor: 2.490

6.  The Evaluation of Fibrin-Related Markers for Diagnosing or Predicting Acute or Subclinical Venous Thromboembolism in Patients Undergoing Major Orthopedic Surgery.

Authors:  Masahiro Hasegawa; Hideo Wada; Shinichi Miyazaki; Toshio Yamaguchi; Hiroki Wakabayashi; Naoki Fujimoto; Takeshi Matsumoto; Kohshi Ohishi; Akane Sakaguchi; Norikazu Yamada; Masaaki Ito; Yoshiki Yamashita; Naoyuki Katayama; Kaname Nakatani; Akihiro Sudo
Journal:  Clin Appl Thromb Hemost       Date:  2016-10-21       Impact factor: 2.389

7.  Comparison of three different anti-Xa assays in major orthopedic surgery patients treated with direct oral anticoagulant.

Authors:  Makoto Ikejiri; Hideo Wada; Shine Tone; Hiroki Wakabayashi; Masahiro Hasegawa; Takeshi Matsumoto; Naoki Fujimoto; Norikazu Yamada; Masaaki Ito; Kaname Nakatani; Akihiro Sudo
Journal:  Thromb J       Date:  2017-10-12

8.  Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux in women at risk after cesarean section.

Authors:  Ryuji Kawaguchi; Shoji Haruta; Hiroshi Kobayashi
Journal:  Obstet Gynecol Sci       Date:  2017-10-17

9.  Elevated D-Dimer Levels Predict a Poor Outcome in Critically Ill Patients.

Authors:  Yuhuko Ichkawa; Hideo Wada; Minoru Ezaki; Motoko Tanaka; Shinya Hiromori; Katsuya Shiraki; Isao Moritani; Akitaka Yamamoto; Haruhiko Tashiro; Hideto Shimpo; Motomu Shimaoka
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

10.  Update on the Clot Waveform Analysis.

Authors:  Hideo Wada; Takeshi Matsumoto; Kohshi Ohishi; Katsuya Shiraki; Motomu Shimaoka
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.